Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.